China Resources Sanjiu Medical & Pharmaceutical Co., Ltd. (SHE:000999)

Market Cap	49.19B
Revenue (ttm)	28.32B
Net Income (ttm)	2.78B
Shares Out	1.67B
EPS (ttm)	1.67
PE Ratio	17.61
Forward PE	11.38
Dividend	1.02 (3.45%)
Ex-Dividend Date	Jun 6, 2025

Volume	8,884,558
Average Volume	17,550,725
Open	30.18
Previous Close	29.25
Day's Range	29.10 - 30.18
52-Week Range	27.88 - 40.42
Beta	0.24
RSI	31.97
Earnings Date	Aug 16, 2025

About SHE:000999

China Resources Sanjiu Medical & Pharmaceutical Co., Ltd. engages in the research and development, production, and sale of pharmaceutical products in the People’s Republic of China and internationally. The company offers health consumer products (CHC), including cold, skin, gastrointestinal, cough, orthopedics, pediatrics drugs, and dietary nutritional supplements; and prescription drug products, such as anti-tumor, cardiovascular and cerebrovascular, digestive system, orthopedics, pediatrics, anti-infection, and other treatment areas; Chinese ...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 1999
• Employees: 20,031
• Stock Exchange: Shenzhen Stock Exchange
• Ticker Symbol: 000999

Financial Performance

In 2024, SHE:000999's revenue was 27.62 billion, an increase of 11.63% compared to the previous year's 24.74 billion. Earnings were 3.37 billion, an increase of 18.05%.